IBDEI1GT ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,23699,1,3,0)
;;=3^Diffuse Cystic Mastopathy,Right Breast
;;^UTILITY(U,$J,358.3,23699,1,4,0)
;;=4^N60.11
;;^UTILITY(U,$J,358.3,23699,2)
;;=^5015773
;;^UTILITY(U,$J,358.3,23700,0)
;;=N60.12^^82^1032^58
;;^UTILITY(U,$J,358.3,23700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23700,1,3,0)
;;=3^Diffuse Cystic Mastopathy,Left Breast
;;^UTILITY(U,$J,358.3,23700,1,4,0)
;;=4^N60.12
;;^UTILITY(U,$J,358.3,23700,2)
;;=^5015774
;;^UTILITY(U,$J,358.3,23701,0)
;;=N73.9^^82^1032^78
;;^UTILITY(U,$J,358.3,23701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23701,1,3,0)
;;=3^Female Pelvic Inflamm Dis,Unspec
;;^UTILITY(U,$J,358.3,23701,1,4,0)
;;=4^N73.9
;;^UTILITY(U,$J,358.3,23701,2)
;;=^5015820
;;^UTILITY(U,$J,358.3,23702,0)
;;=N72.^^82^1032^86
;;^UTILITY(U,$J,358.3,23702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23702,1,3,0)
;;=3^Inflammatory Disease of Cervix Uteri
;;^UTILITY(U,$J,358.3,23702,1,4,0)
;;=4^N72.
;;^UTILITY(U,$J,358.3,23702,2)
;;=^5015812
;;^UTILITY(U,$J,358.3,23703,0)
;;=N76.0^^82^1032^133
;;^UTILITY(U,$J,358.3,23703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23703,1,3,0)
;;=3^Vaginitis,Acute
;;^UTILITY(U,$J,358.3,23703,1,4,0)
;;=4^N76.0
;;^UTILITY(U,$J,358.3,23703,2)
;;=^5015826
;;^UTILITY(U,$J,358.3,23704,0)
;;=N76.1^^82^1032^135
;;^UTILITY(U,$J,358.3,23704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23704,1,3,0)
;;=3^Vaginitis,Subacute & Chronic
;;^UTILITY(U,$J,358.3,23704,1,4,0)
;;=4^N76.1
;;^UTILITY(U,$J,358.3,23704,2)
;;=^5015827
;;^UTILITY(U,$J,358.3,23705,0)
;;=N81.3^^82^1032^128
;;^UTILITY(U,$J,358.3,23705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23705,1,3,0)
;;=3^Uterovaginal Prolapse,Complete
;;^UTILITY(U,$J,358.3,23705,1,4,0)
;;=4^N81.3
;;^UTILITY(U,$J,358.3,23705,2)
;;=^5015840
;;^UTILITY(U,$J,358.3,23706,0)
;;=N81.2^^82^1032^129
;;^UTILITY(U,$J,358.3,23706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23706,1,3,0)
;;=3^Uterovaginal Prolapse,Incomplete
;;^UTILITY(U,$J,358.3,23706,1,4,0)
;;=4^N81.2
;;^UTILITY(U,$J,358.3,23706,2)
;;=^5015839
;;^UTILITY(U,$J,358.3,23707,0)
;;=N81.4^^82^1032^130
;;^UTILITY(U,$J,358.3,23707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23707,1,3,0)
;;=3^Uterovaginal Prolapse,Unspec
;;^UTILITY(U,$J,358.3,23707,1,4,0)
;;=4^N81.4
;;^UTILITY(U,$J,358.3,23707,2)
;;=^5015841
;;^UTILITY(U,$J,358.3,23708,0)
;;=N87.9^^82^1032^67
;;^UTILITY(U,$J,358.3,23708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23708,1,3,0)
;;=3^Dysplasia of Cervix Uteri,Unspec
;;^UTILITY(U,$J,358.3,23708,1,4,0)
;;=4^N87.9
;;^UTILITY(U,$J,358.3,23708,2)
;;=^5015877
;;^UTILITY(U,$J,358.3,23709,0)
;;=N87.0^^82^1032^45
;;^UTILITY(U,$J,358.3,23709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23709,1,3,0)
;;=3^Cervical Dysplasia,Mild
;;^UTILITY(U,$J,358.3,23709,1,4,0)
;;=4^N87.0
;;^UTILITY(U,$J,358.3,23709,2)
;;=^5015875
;;^UTILITY(U,$J,358.3,23710,0)
;;=N87.1^^82^1032^46
;;^UTILITY(U,$J,358.3,23710,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23710,1,3,0)
;;=3^Cervical Dysplasia,Moderate
;;^UTILITY(U,$J,358.3,23710,1,4,0)
;;=4^N87.1
;;^UTILITY(U,$J,358.3,23710,2)
;;=^5015876
;;^UTILITY(U,$J,358.3,23711,0)
;;=N94.6^^82^1032^62
;;^UTILITY(U,$J,358.3,23711,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,23711,1,3,0)
;;=3^Dysmenorrhea,Unspec
;;^UTILITY(U,$J,358.3,23711,1,4,0)
;;=4^N94.6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1GT 3758 printed Oct 16, 2024@18:09:15 Page 2
IBDEI1GT ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,23699,1,3,0)
+2 ;;=3^Diffuse Cystic Mastopathy,Right Breast
+3 ;;^UTILITY(U,$J,358.3,23699,1,4,0)
+4 ;;=4^N60.11
+5 ;;^UTILITY(U,$J,358.3,23699,2)
+6 ;;=^5015773
+7 ;;^UTILITY(U,$J,358.3,23700,0)
+8 ;;=N60.12^^82^1032^58
+9 ;;^UTILITY(U,$J,358.3,23700,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,23700,1,3,0)
+12 ;;=3^Diffuse Cystic Mastopathy,Left Breast
+13 ;;^UTILITY(U,$J,358.3,23700,1,4,0)
+14 ;;=4^N60.12
+15 ;;^UTILITY(U,$J,358.3,23700,2)
+16 ;;=^5015774
+17 ;;^UTILITY(U,$J,358.3,23701,0)
+18 ;;=N73.9^^82^1032^78
+19 ;;^UTILITY(U,$J,358.3,23701,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,23701,1,3,0)
+22 ;;=3^Female Pelvic Inflamm Dis,Unspec
+23 ;;^UTILITY(U,$J,358.3,23701,1,4,0)
+24 ;;=4^N73.9
+25 ;;^UTILITY(U,$J,358.3,23701,2)
+26 ;;=^5015820
+27 ;;^UTILITY(U,$J,358.3,23702,0)
+28 ;;=N72.^^82^1032^86
+29 ;;^UTILITY(U,$J,358.3,23702,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,23702,1,3,0)
+32 ;;=3^Inflammatory Disease of Cervix Uteri
+33 ;;^UTILITY(U,$J,358.3,23702,1,4,0)
+34 ;;=4^N72.
+35 ;;^UTILITY(U,$J,358.3,23702,2)
+36 ;;=^5015812
+37 ;;^UTILITY(U,$J,358.3,23703,0)
+38 ;;=N76.0^^82^1032^133
+39 ;;^UTILITY(U,$J,358.3,23703,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,23703,1,3,0)
+42 ;;=3^Vaginitis,Acute
+43 ;;^UTILITY(U,$J,358.3,23703,1,4,0)
+44 ;;=4^N76.0
+45 ;;^UTILITY(U,$J,358.3,23703,2)
+46 ;;=^5015826
+47 ;;^UTILITY(U,$J,358.3,23704,0)
+48 ;;=N76.1^^82^1032^135
+49 ;;^UTILITY(U,$J,358.3,23704,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,23704,1,3,0)
+52 ;;=3^Vaginitis,Subacute & Chronic
+53 ;;^UTILITY(U,$J,358.3,23704,1,4,0)
+54 ;;=4^N76.1
+55 ;;^UTILITY(U,$J,358.3,23704,2)
+56 ;;=^5015827
+57 ;;^UTILITY(U,$J,358.3,23705,0)
+58 ;;=N81.3^^82^1032^128
+59 ;;^UTILITY(U,$J,358.3,23705,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,23705,1,3,0)
+62 ;;=3^Uterovaginal Prolapse,Complete
+63 ;;^UTILITY(U,$J,358.3,23705,1,4,0)
+64 ;;=4^N81.3
+65 ;;^UTILITY(U,$J,358.3,23705,2)
+66 ;;=^5015840
+67 ;;^UTILITY(U,$J,358.3,23706,0)
+68 ;;=N81.2^^82^1032^129
+69 ;;^UTILITY(U,$J,358.3,23706,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,23706,1,3,0)
+72 ;;=3^Uterovaginal Prolapse,Incomplete
+73 ;;^UTILITY(U,$J,358.3,23706,1,4,0)
+74 ;;=4^N81.2
+75 ;;^UTILITY(U,$J,358.3,23706,2)
+76 ;;=^5015839
+77 ;;^UTILITY(U,$J,358.3,23707,0)
+78 ;;=N81.4^^82^1032^130
+79 ;;^UTILITY(U,$J,358.3,23707,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,23707,1,3,0)
+82 ;;=3^Uterovaginal Prolapse,Unspec
+83 ;;^UTILITY(U,$J,358.3,23707,1,4,0)
+84 ;;=4^N81.4
+85 ;;^UTILITY(U,$J,358.3,23707,2)
+86 ;;=^5015841
+87 ;;^UTILITY(U,$J,358.3,23708,0)
+88 ;;=N87.9^^82^1032^67
+89 ;;^UTILITY(U,$J,358.3,23708,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,23708,1,3,0)
+92 ;;=3^Dysplasia of Cervix Uteri,Unspec
+93 ;;^UTILITY(U,$J,358.3,23708,1,4,0)
+94 ;;=4^N87.9
+95 ;;^UTILITY(U,$J,358.3,23708,2)
+96 ;;=^5015877
+97 ;;^UTILITY(U,$J,358.3,23709,0)
+98 ;;=N87.0^^82^1032^45
+99 ;;^UTILITY(U,$J,358.3,23709,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,23709,1,3,0)
+102 ;;=3^Cervical Dysplasia,Mild
+103 ;;^UTILITY(U,$J,358.3,23709,1,4,0)
+104 ;;=4^N87.0
+105 ;;^UTILITY(U,$J,358.3,23709,2)
+106 ;;=^5015875
+107 ;;^UTILITY(U,$J,358.3,23710,0)
+108 ;;=N87.1^^82^1032^46
+109 ;;^UTILITY(U,$J,358.3,23710,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,23710,1,3,0)
+112 ;;=3^Cervical Dysplasia,Moderate
+113 ;;^UTILITY(U,$J,358.3,23710,1,4,0)
+114 ;;=4^N87.1
+115 ;;^UTILITY(U,$J,358.3,23710,2)
+116 ;;=^5015876
+117 ;;^UTILITY(U,$J,358.3,23711,0)
+118 ;;=N94.6^^82^1032^62
+119 ;;^UTILITY(U,$J,358.3,23711,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,23711,1,3,0)
+122 ;;=3^Dysmenorrhea,Unspec
+123 ;;^UTILITY(U,$J,358.3,23711,1,4,0)
+124 ;;=4^N94.6
